Olympus Recalls ShockPulse-SE Lithotripsy System Generators Over Recognition Failure

Source: FDA · Worldwide

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Olympus Corporation of the Americas has recalled 1,684 ShockPulse-SE Lithotripsy System generators due to hardware damage that prevents the device from recognizing the transducer.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on April 2, 2026 and geographically references Worldwide. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.

What Happened

Olympus Corporation of the Americas has initiated a voluntary recall of the ShockPulse-SE Lithotripsy System generator. According to the FDA, investigations identified instances where the generator remains in a "blinking phase" while waiting to recognize the transducer. This malfunction is caused by damage to the transducer plug and/or the generator receptacle.

Which Products Are Affected

The recall affects the following medical device:

  • Brand Name: ShockPulse-SE Lithotripsy System
  • Product Name: ShockPulse-SE Lithotripsy System - Generator
  • Model/Catalog Number: SPL-G
  • UDI: 00821925044203
  • Serial Numbers: All serial numbers are included in this recall.
  • Quantity: 1,684 units
  • Distribution: This is a worldwide distribution, including the United States, Canada, Mexico, Bolivia, Chile, India, China, the European Union, Singapore, Australia, Korea, and Japan.

What You Should Do

Olympus initiated the recall by sending notification letters to affected customers. Healthcare providers and facilities using the ShockPulse-SE system should inspect the transducer plugs and generator receptacles for signs of damage. For more information regarding the recall or to coordinate service, contact Olympus Corporation of the Americas at 3500 Corporate Pkwy, Center Valley, PA 18034.

Why This Matters

The ShockPulse-SE system is used to fragment stones (calculi) during medical procedures. If the generator fails to recognize the transducer, the device cannot generate the necessary mechanical impacts or ultrasonic energy, potentially leading to procedural delays or equipment failure during surgery.

Source

Information provided by the FDA. Recall Number: Z-1479-2026.

Original source: FDA Official Notice ↗

All FDA Recalls →

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Olympus Corporation of the Americas has recalled 1,684 ShockPulse-SE Lithotripsy System generators due to hardware damage that prevents the device from recognizing the transducer.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects Worldwide. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.